Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM76O23)

Drug Name

KW-6055 Drug Info

Synonyms

N-[3-Nitro-4-(2-pyridinylmethyl)phenyl]butanamide; 2-[4-(Butyrylamino)-2-nitrobenzyl]pyridine

Indication

Disease Entry	ICD 11	Status	REF
Inflammation	1A00-CA43.1	Discontinued in Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Acetylcholine release (Ach rele)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Incobotulinum toxin A	DMKE6YT	Cervical cancer	2C77.0	Approved	[3]
Abobotulinum toxin A	DMZT2P0	Cervical cancer	2C77.0	Approved	[4]
HOE-065	DMNC1A3	Cognitive impairment	6D71	Discontinued in Phase 1	[5]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Acetylcholine release (Ach rele)	TTZJD1B	NOUNIPROTAC	Modulator	[2]

------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000699)
2	Effects of KW-6055, a novel benzylpyridine derivative, on central cholinergic systems. Nihon Yakurigaku Zasshi. 1992 Jun;99(6):435-43.
3	Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
4	Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
5	Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents. Eur J Pharmacol. 1989 Nov 14;171(1):79-85.